Ping An, Samsung, CLP, Tasly and Health 100 have all taken part in a series C round for the diabetes management technology provider.
China-based healthcare management platform Kang Sheng Health Management has closed a $100m series C round co-led by energy utility CLP, China Money Network reported on Sunday, citing an announcement on WeChat.
Investment banking firm China International Capital Corporation co-led the round, which included Samsung Ventures, a subsidiary of electronics producer Samsung, as well as pharmaceutical company Tasly, insurer Ping An, medical analytics provider Health 100, IDG Capital and LB Investment.
Kang Sheng’s mobile app, Zhangshang Tangyi, enables patients suffering from…